BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21181521)

  • 21. Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment.
    Harezlak J; Buchthal S; Taylor M; Schifitto G; Zhong J; Daar E; Alger J; Singer E; Campbell T; Yiannoutsos C; Cohen R; Navia B;
    AIDS; 2011 Mar; 25(5):625-33. PubMed ID: 21297425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of armodafinil on cognition in patients with HIV/AIDS and fatigue.
    McElhiney M; Rabkin J; Van Gorp W; Rabkin R
    J Clin Exp Neuropsychol; 2013; 35(7):718-27. PubMed ID: 23944194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men.
    Burack JH; Barrett DC; Stall RD; Chesney MA; Ekstrand ML; Coates TJ
    JAMA; 1993 Dec; 270(21):2568-73. PubMed ID: 7901433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection.
    Jacobson JM; Lederman MM; Spritzler J; Valdez H; Tebas P; Skowron G; Wang R; Jackson JB; Fox L; Landay A; Gilbert MJ; O'Neil D; Bancroft L; Al-Harthi L; Jacobson MA; Merigan TC; Glesby MJ;
    J Infect Dis; 2003 Dec; 188(12):1804-14. PubMed ID: 14673758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton spectroscopy in asymptomatic HIV-infected adults: initial results in a prospective cohort study.
    Jarvik JG; Lenkinski RE; Saykin AJ; Jaans A; Frank I
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Nov; 13(3):247-53. PubMed ID: 8898669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive Performance and Neuro-Metabolites in HIV Using 3T Magnetic Resonance Spectroscopy: A Cross-Sectional Study from India.
    Gupta K; Shivabalan ; Kumar V; Vyas S; Pandey RM; Jagannathan NR; Sinha S
    Curr HIV Res; 2021; 19(2):147-153. PubMed ID: 33106144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.
    Walson JL; Otieno PA; Mbuchi M; Richardson BA; Lohman-Payne B; Macharia SW; Overbaugh J; Berkley J; Sanders EJ; Chung MH; John-Stewart GC
    AIDS; 2008 Aug; 22(13):1601-9. PubMed ID: 18670219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.
    Currier JS; Williams PL; Koletar SL; Cohn SE; Murphy RL; Heald AE; Hafner R; Bassily EL; Lederman HM; Knirsch C; Benson CA; Valdez H; Aberg JA; McCutchan JA
    Ann Intern Med; 2000 Oct; 133(7):493-503. PubMed ID: 11015162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moderate to severe HIV-associated neurocognitive impairment: A randomized placebo-controlled trial of lithium.
    Decloedt EH; Freeman C; Howells F; Casson-Crook M; Lesosky M; Koutsilieri E; Lovestone S; Maartens G; Joska JA
    Medicine (Baltimore); 2016 Nov; 95(46):e5401. PubMed ID: 27861379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.
    Anderson AM; Muñoz-Moreno JA; McClernon DR; Ellis RJ; Cookson D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; McCutchan JA; Morgello S; Sacktor N; Simpson DM; Franklin DR; Heaton RK; Grant I; Letendre SL;
    J Infect Dis; 2017 Jan; 215(1):105-113. PubMed ID: 27789723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.
    D'Antoni ML; Kallianpur KJ; Premeaux TA; Corley MJ; Fujita T; Laws EI; Ogata-Arakaki D; Chow DC; Khadka VS; Shikuma CM; Ndhlovu LC
    Front Immunol; 2019; 10():2789. PubMed ID: 31849969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts.
    Vigneswaran S; Rojas JH; Garvey L; Taylor-Robinson S; Winston A
    Neuroradiol J; 2015 Dec; 28(6):545-54. PubMed ID: 26493269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team.
    Hughes MD; Johnson VA; Hirsch MS; Bremer JW; Elbeik T; Erice A; Kuritzkes DR; Scott WA; Spector SA; Basgoz N; Fischl MA; D'Aquila RT
    Ann Intern Med; 1997 Jun; 126(12):929-38. PubMed ID: 9182469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
    Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
    Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals. North American Lamivudine HIV Working Group.
    Phillips AN; Eron J; Bartlett J; Kuritzkes DR; Johnson VA; Gilbert C; Johnson J; Keller A; Hill AM
    AIDS; 1997 Feb; 11(2):169-75. PubMed ID: 9030363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients.
    Ciccarelli N; Grima P; Fabbiani M; Baldonero E; Borghetti A; Milanini B; Limiti S; Colafigli M; Tamburrini E; Cauda R; De Luca A; Di Giambenedetto S
    Antivir Ther; 2015; 20(4):433-40. PubMed ID: 25504667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity.
    Paul RH; Yiannoutsos CT; Miller EN; Chang L; Marra CM; Schifitto G; Ernst T; Singer E; Richards T; Jarvik GJ; Price R; Meyerhoff DJ; Kolson D; Ellis RJ; Gonzalez G; Lenkinski RE; Cohen RA; Navia BA
    J Neuropsychiatry Clin Neurosci; 2007; 19(3):283-92. PubMed ID: 17827413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients.
    Meyerhoff DJ; Bloomer C; Cardenas V; Norman D; Weiner MW; Fein G
    Neurology; 1999 Mar; 52(5):995-1003. PubMed ID: 10102419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial. Paediatric European Network for Treatment of AIDS.
    AIDS; 1998 Oct; 12(14):F151-60. PubMed ID: 9792371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized placebo-controlled trial of adefovir dipivoxil in advanced HIV infection: the ADHOC trial.
    ADHOC International Steering Committee
    HIV Med; 2002 Oct; 3(4):229-38. PubMed ID: 12444940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.